Schultes R.E.

Hofmann A. Plants of the Gods: their sacred, healing, and hallucinogenic powers. Healing Arts Press , Rochester, VT View in Article Google Scholar

Riba J.

Valle M.

Urbano G.

Yritia M.

Morte A.

Barbanoj M.J. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther. 306 : 73-83 View in Article Scopus (176)

PubMed

Crossref

Google Scholar

dos Santos R.G.

Osório F.L.

Crippa J.A.

Hallak J.E. Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies. Rev Bras Psiquiatr. 38 : 65-72 View in Article Google Scholar

Nunes A.A.

Dos Santos R.G.

Osório F.L.

Sanches R.F.

Crippa J.A.

Hallak J.E. Effects of ayahuasca and its alkaloids on drug dependence: a systematic literature review of quantitative studies in animals and humans. J Psychoactive Drugs. 48 : 195-205 View in Article Google Scholar

Dos Santos R.G.

Hallak J.E. Effects of the natural β-carboline alkaloid harmine, a main constituent of ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies. J Psychoactive Drugs. 49 : 1-10 View in Article Google Scholar

Moreno J.L.

Holloway T.

Albizu L.

Sealfon S.C.

González-Maeso J. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT 2A receptor agonists. Neurosci Lett. 493 : 76-79 View in Article Scopus (130)

PubMed

Crossref

Google Scholar

Cameron L.P.

Benson C.J.

DeFelice B.C.

Fiehn O.

Olson D.E. Chronic, intermittent microdoses of the psychedelic N, N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents. ACS Chem Neurosci. https://doi.org/10.1021/acschemneuro.8b00692 View in Article Scopus (14)

Crossref

Google Scholar

Nichols D.E. N,N-dimethyltryptamine and the pineal gland: separating fact from myth. J Psychopharmacol. 32 : 30-36 View in Article Google Scholar

Frecska E.

Szabo A.

Winkelman M.J.

Luna L.E.

McKenna D.J. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm. 120 : 1295-1303 View in Article Google Scholar

Szabo A.

Kovacs A.

Frecska E.

Rajnavolgyi E. Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PLoS One. 9 e106533 View in Article Google Scholar

Fortunato J.J.

Réus G.Z.

Kirsch T.R.

Stringari R.B.

Stertz L.

Kapczinski F.

et al. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 33 : 1425-1430 View in Article Google Scholar

Fortunato J.J.

Réus G.Z.

Kirsch T.R.

Stringari R.B.

Fries G.R.

Kapczinski F.

et al. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. J Neural Transm. 117 : 1131-1137 View in Article Google Scholar

Dakic V.

Maciel R.M.

Drummond H.

Nascimento J.M.

Trindade P.

Rehen S.K. Harmine stimulates proliferation of human neural progenitors. PeerJ. 4 : e2727 View in Article Google Scholar

Bouso J.C.

González D.

Fondevila S.

Cutchet M.

Fernández X.

Ribeiro Barbosa P.C.

et al. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study. PLoS One. 7 e42421 View in Article Scopus (104)

PubMed

Crossref

Google Scholar

Dos Santos R.G.

Balthazar F.M.

Bouso J.C.

Hallak J.E. The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol. 30 : 1230-1247 View in Article Google Scholar

Ona G.

Kohek M.

Massaguer T.

Gomariz A.

Jiménez D.F.

Dos Santos R.G.

et al. Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. J Psychoactive Drugs. https://doi.org/10.1080/02791072.2019.1567961 View in Article Scopus (6)

Crossref

Google Scholar

Dos Santos R.G.

Landeira-Fernandez J.

Strassman R.J.

Motta V.

Cruz A.P. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. J Ethnopharmacol. 112 : 507-513 View in Article Google Scholar

Sanches R.F.

de Lima Osório F.

Dos Santos R.G.

Macedo L.R.

Maia-de-Oliveira J.P.

Wichert-Ana L.

et al. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol. 36 : 77-81 View in Article Scopus (114)

PubMed

Crossref

Google Scholar

Palhano-Fontes F.

Barreto D.

Onias H.

Andrade K.C.

Novaes M.M.

Pessoa J.A.

et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med. 49 : 655-663 View in Article Scopus (72)

PubMed

Crossref

Google Scholar

Riba J.

Rodríguez-Fornells A.

Urbano G.

Morte A.

Antonijoan R.

Montero M.

et al. Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology. 154 : 85-95 View in Article Scopus (129)

PubMed

Crossref

Google Scholar

Studerus E.

Kometer M.

Hasler F.

Vollenweider F.X. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol. 25 : 1434-1452 View in Article Scopus (143)

PubMed

Crossref

Google Scholar

De Araujo D.B.

Ribeiro S.

Cecchi G.A.

Carvalho F.M.

Sanchez T.A.

Pinto J.P.

et al. Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion. Hum Brain Mapp. 33 : 2550-2560 View in Article Scopus (80)

PubMed

Crossref

Google Scholar

Gasser P.

Holstein D.

Michel Y.

Doblin R.

Yazar-Klosinski B.

Passie T.

et al. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 202 : 513-520 View in Article Scopus (179)

PubMed

Crossref

Google Scholar

Griffiths R.R.

Johnson M.W.

Carducci M.A.

Umbricht A.

Richards W.A.

Richards B.D.

et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 30 : 1181-1197 View in Article Scopus (260)

PubMed

Crossref

Google Scholar

Ross S.

Bossis A.

Guss J.

Agin-Liebes G.

Malone T.

Cohen B.

et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 30 : 1165-1180 View in Article Scopus (239)

PubMed

Crossref

Google Scholar

Valle M.

Maqueda A.E.

Rabella M.

Rodríguez-Pujadas A.

Antonijoan R.M.

Romero S.

et al. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. Eur Neuropsychopharmacol. 26 : 1161-1175 View in Article Scopus (49)

Crossref

Google Scholar

Dos Santos R.G.

Osório F.L.

Crippa J.A.

Riba J.

Zuardi A.W.

Hallak J.E. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol. 6 : 193-213 View in Article Google Scholar

Dos Santos R.G.

Bouso J.C.

Alcázar-Córcoles M.Á.

Hallak J.E.C. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol. 11 : 889-902 View in Article Google Scholar

Tófoli L.F.

de Araujo D.B. Treating addiction: perspectives from EEG and imaging studies on psychedelics. Int Rev Neurobiol. 129 : 157-185 View in Article Google Scholar

Riba J.

Anderer P.

Morte A.

Urbano G.

Jané F.

Saletu B.

et al. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol. 53 : 613-628 View in Article Scopus (70)

PubMed

Crossref

Google Scholar

Riba J.

Anderer P.

Jané F.

Saletu B.

Barbanoj M.J. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology. 50 : 89-101 View in Article Scopus (67)

PubMed

Crossref

Google Scholar

Dos Santos R.G.

Valle M.

Bouso J.C.

Nomdedéu J.F.

Rodríguez-Espinosa J.

McIlhenny E.H.

et al. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. J Clin Psychopharmacol. 31 : 717-726 View in Article Google Scholar

Dos Santos R.G.

Grasa E.

Valle M.

Ballester M.R.

Bouso J.C.

Nomdedéu J.F.

et al. Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology. 219 : 1039-1053 View in Article Google Scholar

Schenberg E.E.

Alexandre J.F.

Filev R.

Cravo A.M.

Sato J.R.

Muthukumaraswamy S.D.

et al. Acute biphasic effects of ayahuasca. PLoS One. 10 e0137202 View in Article Google Scholar

Kometer M.

Schmidt A.

Jäncke L.

Vollenweider F.X. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. J Neurosci. 33 : 10544-10551 View in Article Scopus (113)

PubMed

Crossref

Google Scholar

Carhart-Harris R.L.

Muthukumaraswamy S.

Roseman L.

Kaelen M.

Droog W.

Murphy K.

et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 113 : 4853-4858 View in Article Scopus (193)

PubMed

Crossref

Google Scholar

Palhano-Fontes F.

Andrade K.C.

Tofoli L.F.

Santos A.C.

Crippa J.A.

Hallak J.E.

et al. The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One. 10 e0118143 View in Article Scopus (106)

PubMed

Crossref

Google Scholar

Bouso J.C.

Palhano-Fontes F.

Rodríguez-Fornells A.

Ribeiro S.

Sanches R.

Crippa J.A.

et al. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol. 25 : 483-492 View in Article Scopus (65)

Crossref

Google Scholar

Bouso J.C.

Dos Santos R.G.

Alcázar-Córcoles M.Á.

Hallak J.E.C. Serotonergic psychedelics and personality: a systematic review of contemporary research. Neurosci Biobehav Rev. 87 : 118-132 View in Article Google Scholar

Dos Santos R.G.

Crippa J.A.

Osório F.L.

Rocha J.M.

Rossi G.N.

Marchioni C.

et al. Possible interactions between 5-HT 2A receptors and the endocannabinoid system in humans: preliminary evidence of interactive effects of ayahuasca and endocannabinoids in a healthy human subject. J Clin Psychopharmacol. 38 : 644-646 View in Article Google Scholar

Meldrum B.S.

Naquet R. Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio). Br J Pharmacol. 40 : 144P-5P View in Article Google Scholar

Wada Y.

Hasegawa H.

Nakamura M.

Yamaguchi N. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neurosci Lett. 138 : 115-118 View in Article Google Scholar

Schwarz B.E.

Bickford R.G.

Mulder D.W.

Rome H.P. Mescaline and LSD-25 in activation of temporal lobe epilepsy. Neurology. 6 : 275-280 View in Article Google Scholar

Serafetinides E.A. The EEG effects of LSD-25 in epileptic patients before and after temporal lobectomy. Psychopharmacologia. 7 : 453-460 View in Article Google Scholar

Fisher D.D.

Ungerleider J.T. Grand mal seizures following ingestion of LSD. Calif Med. 106 : 210-211 View in Article Google Scholar

Heise C.W.

Brooks D.E. Ayahuasca exposure: descriptive analysis of calls to US poison control centers from 2005 to 2015. J Med Toxicol. 13 : 245-248 View in Article Scopus (15)

PubMed

Crossref

Google Scholar

Dos Santos R.G.

Bouso J.C.

Hallak J.E.C. Ayahuasca: what mental health professionals need to know. Arch Clin Psychiatry. 44 : 103-109 View in Article Google Scholar

Dos Santos R.G.

Bouso J.C.

Hallak J.E. Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol. 7 : 141-157 View in Article PubMed

Crossref

Google Scholar

De Gregorio D.

Comai S.

Posa L.

Gobbi G. d -Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology. Int J Mol Sci. 17 ( ) View in Article Google Scholar

Gable R.S. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction. 99 : 686-696 View in Article Google Scholar

Sanchez-Ramos J.R. Banisterine and Parkinson's disease. Clin Neuropharmacol. 14 : 391-402 View in Article Google Scholar

Schwarz M.J.

Houghton P.J.

Rose S.

Jenner P.

Lees A.D. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. Pharmacol Biochem Behav. 75 : 627-633 View in Article Google Scholar